AEON Biopharma (AEON) Stock: Buy, Sell, or Hold?
AEON - AEON Biopharma, Inc.
$0.30
0.04 (15.83%)
▲
5d:
+13.68%
30d:
+1.39%
90d:
-57.81%
WAIT
LOW Confidence
Analysis Updated: Sep 30, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When AEON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: AEON shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: AEON shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: AEON is currently trading at $0.30, which is considered extended relative to its 30-day fair value range of $0.23 to $0.29.
Technical Outlook: Technically, AEON is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.42. The stock is showing strong short-term momentum, up 15.8% recently.
Market Sentiment: AEON scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.52 (+408.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEON is in a strong downtrend. Immediate support is located at $0.23, while resistance sits at $0.42. The stock is showing strong short-term momentum, up 15.8% recently.
Market Sentiment: AEON scores 13/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.52 (+408.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.23 -
$0.29
Company Quality Score
27/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (13/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+15.8%)
- BULLISH: Trading 408.3% below Wall St target ($1.52)
- WARNING: Composite score 27/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.23 -
$0.29
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.23
Resistance Level
$0.42
Current Trend
Strong Downtrend
Technical data as of
Sep 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.11
Wall Street Target
$1.53
(+408.3%)
Share & Embed Analysis
Last updated: September 30, 2026 8:23 PM ET
Data refreshes hourly during market hours. Next update: 9:23 PM
Data refreshes hourly during market hours. Next update: 9:23 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 49 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$851 | 58 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$293 | 57 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$29 | 47 HOLD |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$37 | 62 BUY |
